We are aware that Eli Lilly and Co, the producers of Mounjaro are planning to increase the cost of supply by 170% from the 1st of September.
As a surgery we fully understand this medication has helped some patients achieve significant weight loss when supplied from private providers. We also understand if the price rises by the same percentage for consumers and patients, this may make it too expensive for some patients to continue. Unfortunately, we will not be able to supply it in these circumstances unless meeting the NHS Criteria included in our post on the 19th of June. Those patients meeting the criteria have already been contacted by the surgery.